Le point sur la tuberculose multirésistante en Suisse

Article Article scientifique Article Le point sur la tuberculose multirésistante en Suisse fre 2016 author Knuchel Judith 583432 author Lador Frédéric 89384 author Gasche-Soccal Paola Marina Alessandra 33623 author Janssens Jean-Paul 30742 1948-1954 28696636 1660-9379 Multi-resistant tuberculosis (MDR-TB) is a world-wide public-health problem with about half a million cases/year (of a total of 9 million cases of TB). Patients at highest risk for MDR-TB are those who have already been treated. Among other risk factors are: contact with an index case of MDR-TB, being a migrant, and originating from a country with a high incidence of MDR-TB. Switzerland has had so far a relatively small number of MDR-TB cases, with a slight increase over the past few years. Use of PCR and genotypic antibiograms allow a rapid detection of MDR-TB cases as well as initiating a more adapted treatment, which must however be finally adjusted on the basis of the phenotypic antibiogram. Treatment is long, costly and tedious, even if, based on recent data, there is a hope for shorter treatments (9‑12 months). Dewey 616 56 Département de médecine 221 false 952 Groupe Gasche-Soccal Paola 958 Revue médicale suisse 12 539 e65e35e4-09a6-4022-ad52-ac6d1b5209e5 Article (Published version) Public RMS_539_1948.pdf 2951241 application/pdf Restricted 2018-11-16 openAccess Faculté de médecine / Section de médecine clinique / Département de médecine

Title	Published in	Access level	OA Policy	Year	Views	Downloads

Le point sur la tuberculose multirésistante en Suisse	Revue médicale suisse			2016	535	506

Archive ouverte UNIGE

Knuchel, Judith